Rapamycin treatment dose‐dependently improves the cystic kidney in a new <scp>ADPKD</scp> mouse model <i>via</i> the <scp>mTORC</scp>1 and cell‐cycle‐associated <scp>CDK</scp>1/cyclin axis
Journal of Cellular and Molecular Medicine